← Back to Search

Web-Based Exercise Program for Obesity

N/A
Recruiting
Led By Jacob Kariuki, PhD, NP
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 6
Awards & highlights

Study Summary

This trial tests if exercise can help obese adults stay fit and healthy.

Who is the study for?
This trial is for adults with obesity who are not very active, have a BMI of 30 or higher, and don't exercise much (less than 150 minutes of moderate activity per week). They must be able to use the internet regularly and track their physical activity. People can't join if they're pregnant, planning to get pregnant soon, have mobility issues, need supervised exercise due to certain conditions like stroke or heart disease unless cleared by a doctor.Check my eligibility
What is being tested?
The study tests the PATH intervention—a web-based program designed to increase physical activity—against an attention control group that receives dietary education. Participants will also use a physical activity tracker to monitor their progress.See study design
What are the potential side effects?
Since this trial involves lifestyle changes rather than medication, side effects may include muscle soreness or injury from new physical activities. The risk is low but participants should start any new exercise gradually and under guidance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in 2013 Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator
Change in Number of Participants Adhering to PA Guidelines
Change in Step Count
+1 more
Secondary outcome measures
Change in Adiponectin
Change in Diastolic Blood Pressure
Change in Hemoglobin A1c
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PATH InterventionExperimental Treatment3 Interventions
Insufficiently active adults with obesity assigned to the PATH intervention.
Group II: Attention Control GroupActive Control3 Interventions
Insufficiently active adults with obesity assigned to the attention control group. At the end of the 6-month study period, participants will receive access to the PATH program, with out the coaching component.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary education
2015
N/A
~70
PATH Intervention
2021
N/A
~80

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,638 Previous Clinical Trials
2,560,444 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,836 Previous Clinical Trials
47,850,807 Total Patients Enrolled
Jacob Kariuki, PhD, NPPrincipal InvestigatorEmory University
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

PATH Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05803304 — N/A
Cardiovascular Disease Research Study Groups: PATH Intervention, Attention Control Group
Cardiovascular Disease Clinical Trial 2023: PATH Intervention Highlights & Side Effects. Trial Name: NCT05803304 — N/A
PATH Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05803304 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional participants being sought for this experiment?

"According to clinicaltrials.gov, this trial has concluded its recruitment process after first launching on May 1st 2023 and last updating the page on March 26th of that same year. Nevertheless, there are currently 409 other clinical trials seeking patient enrolment."

Answered by AI

What are the objectives of this research endeavor?

"As the main metric of this trial, its researchers will measure participants' adherence to physical activity guidelines across a baseline and 6-month period. Secondly, changes in weight (measured in kilograms), systolic blood pressure (normally <120 mmHg) and diastolic blood pressure (generally <80 mmHg) are being monitored as well."

Answered by AI
~35 spots leftby Aug 2024